CVRX
CVRx IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$129.76M
P/E Ratio
—
EPS
$-2.01
Beta
0.77
52W High
$11.30
52W Low
$4.37
50-Day MA
$6.76
200-Day MA
$7.79
Dividend Yield
—
Profit Margin
-89.10%
Forward P/E
—
PEG Ratio
—
About CVRx Inc
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
Fundamentals
| Revenue (TTM) | $59.07M |
| Gross Profit (TTM) | $50.91M |
| EBITDA | $-49.21M |
| Operating Margin | -82.30% |
| Return on Equity | -107.00% |
| Return on Assets | -27.30% |
| Revenue/Share (TTM) | $2.25 |
| Book Value | $1.10 |
| Price-to-Book | 4.46 |
| Price-to-Sales (TTM) | 2.20 |
| EV/Revenue | 1.98 |
| EV/EBITDA | -1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 19.60% |
| Shares Outstanding | $26.54M |
| Float | $18.33M |
| % Insiders | 9.55% |
| % Institutions | 63.56% |
Historical Volatility
HV 10-Day
80.29%
HV 20-Day
61.72%
HV 30-Day
103.27%
HV 60-Day
89.73%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($11.17 target)
1
Strong Buy5
Buy1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026